LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 332

Search options

  1. Book ; Conference proceedings: Evolving issues in oncology - What is the optimal hemoglobin level? / 2 / Contributors Matti S. Aapro ...

    Aprile, Giuseppe / Aapro, Matti S. / Dicato, Mario

    [based on the proceedings of a Symposium Evolving Issues in Oncology: What is the Optimal Hemoglobin Level? held ... September 7 - 9, 2000, in Seville, Spain]

    (Seminars in oncology ; 29,3, Suppl. 8)

    2002  

    Event/congress Symposium Evolving Issues in Oncology: What is the Optimal Hemoglobin Level? (2000, Sevilla)
    Author's details Mario Dicato ... guest ed
    Series title Seminars in oncology ; 29,3, Suppl. 8
    Evolving issues in oncology - What is the optimal hemoglobin level?
    Collection Evolving issues in oncology - What is the optimal hemoglobin level?
    Language English
    Size 91 S. : Ill., graph. Darst.
    Publisher Saunders
    Publishing place Philadelphia, Pa
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT013399419
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Article: Therapiemanagement von älteren Patientinnen mit Brustkrebs. Interview mit Dr. Matti S. Aapro

    Aapro, Matti S.

    Gyn Spektrum

    2005  Volume 13, Issue 1, Page(s) 6

    Language German
    Document type Article
    ZDB-ID 1193386-0
    ISSN 1436-7580
    Database Current Contents Medicine

    More links

    Kategorien

  3. Book: Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting

    Aapro, Matti S.

    (Supportive care in cancer ; volume 26, supplement 1 (March 2018))

    2018  

    Title variant Special section title: Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting
    Author's details guest editor: Matti Aapro, MD
    Series title Supportive care in cancer ; volume 26, supplement 1 (March 2018)
    Collection
    Language English
    Size S37 Seiten, Illustrationen
    Publisher Springer
    Publishing place Berlin
    Publishing country Germany
    Document type Book
    HBZ-ID HT019695961
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Article ; Online: Characteristics of nausea and its impact on health-related quality of life in cisplatin-treated patients receiving dexamethasone-sparing prophylaxis: an analysis of the LUNG-NEPA study.

    Celio, Luigi / Aapro, Matti

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

    2024  Volume 32, Issue 3, Page(s) 204

    Abstract: Purpose: We investigated the intensity and duration of nausea as well as its impact on health-related quality of life among cisplatin-treated patients who participated in a study of dexamethasone (DEX)-sparing regimens based on NEPA (netupitant/ ... ...

    Abstract Purpose: We investigated the intensity and duration of nausea as well as its impact on health-related quality of life among cisplatin-treated patients who participated in a study of dexamethasone (DEX)-sparing regimens based on NEPA (netupitant/palonosetron).
    Methods: This retrospective analysis included chemo-naive patients from a trial evaluating non-inferiority of DEX on day 1 (DEX1 arm) combined with NEPA, compared with the same regimen with DEX administered on days 1-4 (DEX4; reference arm) following cisplatin (≥ 70 mg/m
    Results: In the DEX1 arm, more patients (20/76) experienced acute nausea, influencing the outcome of delayed nausea (38/76). During days 1 to 5, 51.3% (39/76) and 39.5% (30/76) of patients experienced nausea in the DEX1 and DEX4 arms, respectively (P = 0.192). Of these, 43.6% and 60% reported moderate-to-severe nausea, respectively, in the DEX1 and DEX4 arms (P = 0.200), while 74.4% and 56.7% of patients experienced extended nausea duration (P = 0.122). Similar between-arm rates of nauseated patients reported an impact on daily life (79.5% vs. 70%; P = 0.408). In analyses stratified for antiemetic regimen, moderate-to-severe nausea or extended nausea duration was associated with an impact on daily life (P ≤ 0.001).
    Conclusion: Despite the higher incidence, there was no suggestion of any strong adverse effect of NEPA plus single-dose DEX on the characteristics of nausea as well as its impact on daily life in patients with cisplatin-induced nausea. Further prospective controlled study is warranted.
    Trial registration: ClinicalTrials.gov identifier: NCT04201769. Registration date: 17/12/2019.
    MeSH term(s) Humans ; Quality of Life ; Cisplatin/adverse effects ; Retrospective Studies ; Nausea/chemically induced ; Nausea/epidemiology ; Nausea/prevention & control ; Dexamethasone/therapeutic use ; Lung
    Chemical Substances Cisplatin (Q20Q21Q62J) ; Dexamethasone (7S5I7G3JQL)
    Language English
    Publishing date 2024-03-04
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1134446-5
    ISSN 1433-7339 ; 0941-4355
    ISSN (online) 1433-7339
    ISSN 0941-4355
    DOI 10.1007/s00520-024-08406-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book: New and emerging therapeutic options for the management of chemotherapy-induced nausea and vomiting

    Schwartzberg, Lee S. / Rugo, Hope S. / Aapro, Matti S.

    (Clinical advances in hematology & oncology : Clinical roundtable monograph ; volume 13, issue 3, supplement 3 (March 2015))

    2015  

    Author's details discussants Lee S. Schwartzberg, MD; Hope S. Rugo, MD; Matti S. Aapro, MD
    Series title Clinical advances in hematology & oncology : Clinical roundtable monograph ; volume 13, issue 3, supplement 3 (March 2015)
    Clinical advances in hematology & oncology
    Clinical advances in hematology & oncology
    Collection Clinical advances in hematology & oncology
    Clinical advances in hematology & oncology
    Language English
    Size 14 Seiten, Diagramme
    Publisher Millennium Medical Publishing
    Publishing place New York, NY
    Publishing country United States
    Document type Book
    HBZ-ID HT019339121
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  6. Book: Advances in the management of chemotherapy-induced nausea and vomiting: new data from recent and ongoing trials

    Wong, Eric T. / Aapro, Matti S. / Schwartzberg, Lee S.

    (Clinical advances in hematology & oncology : Clinical roundtable monograph ; volume 13, issue 10, supplement 10 (October 2015))

    2015  

    Author's details discussants Eric Roeland, MD; Matti S. Aapro, MD; Lee S. Schwartzberg, MD
    Series title Clinical advances in hematology & oncology : Clinical roundtable monograph ; volume 13, issue 10, supplement 10 (October 2015)
    Clinical advances in hematology & oncology
    Clinical advances in hematology & oncology
    Collection Clinical advances in hematology & oncology
    Clinical advances in hematology & oncology
    Language English
    Size 14 Seiten, Diagramme
    Publisher Millennium Medical Publishing
    Publishing place New York, NY
    Publishing country United States
    Document type Book
    HBZ-ID HT019339012
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  7. Book: Prevention of nausea and vomiting in cancer patients

    Aapro, Matti S. / Jordan, Karin / Feyer, Petra

    2013  

    Author's details Matti Aapro ; Karin Jordan ; Petra Feyer
    Language English
    Size IX, 59 S. : Ill.
    Publisher Springer Healthcare
    Publishing place London
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT018105170
    ISBN 978-1-908517-87-6 ; 1-908517-87-5
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  8. Article ; Online: Comment on "Dexamethasone-sparing on days 2-4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)".

    Celio, Luigi / Antonuzzo, Andrea / Aapro, Matti S

    British journal of cancer

    2024  Volume 130, Issue 6, Page(s) 895–896

    MeSH term(s) Humans ; Cisplatin ; Clinical Trials, Phase III as Topic ; Dexamethasone ; Neurokinin-1 Receptor Antagonists/therapeutic use ; Olanzapine ; Randomized Controlled Trials as Topic
    Chemical Substances Cisplatin (Q20Q21Q62J) ; Dexamethasone (7S5I7G3JQL) ; Neurokinin-1 Receptor Antagonists ; Olanzapine (N7U69T4SZR)
    Language English
    Publishing date 2024-02-26
    Publishing country England
    Document type Letter
    ZDB-ID 80075-2
    ISSN 1532-1827 ; 0007-0920
    ISSN (online) 1532-1827
    ISSN 0007-0920
    DOI 10.1038/s41416-024-02611-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Book ; Conference proceedings: Moving forward with new data and approaches: a fresh look at anthracyclines in breast cancer

    Amadori, Dino / Aapro, Matti S.

    summary of a workshop held in September 2010 [International Workshop Moving Forward With New Data and Approaches: A Fresh Look at Anthracyclines in Breast Cancer and NHL]

    (EJC Supplements ; 9,2)

    2011  

    Event/congress International Workshop Moving Forward With New Data and Approaches: A Fresh Look at Anthracyclines in Breast Cancer and NHL (2010, Meldola)
    Author's details guest ed.: Dino Amadori and Matti Aapro
    Series title EJC Supplements ; 9,2
    European journal of cancer
    Collection European journal of cancer
    Language English
    Size 42 S. : graph. Darst.
    Publisher Elsevier
    Publishing place Amsterdam u.a.
    Publishing country Netherlands
    Document type Book ; Conference proceedings
    HBZ-ID HT017108280
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  10. Book ; Conference proceedings: Optimizng breast cancer patient care today and tomorrow

    Aapro, Matti S.

    implications for clinicians ; [2007 Educational Breast Care Meeting "Optimizing Breast Cancer Patient Care Today and Tomorrow: Implications for Clinicians", held in Barcelona, Spain]

    (Breast cancer research and treatment ; 112, Suppl. 1)

    2008  

    Event/congress Educational Breast Care Meeting Optimizing Breast Cancer Patient Care Today and Tomorrow: Implications for Clinicians (2007, Barcelona)
    Author's details guest ed. Matti S. Aapro
    Series title Breast cancer research and treatment ; 112, Suppl. 1
    Collection
    Language English
    Size 66 S. : graph. Darst.
    Publisher Springer
    Publishing place Dordrecht u.a.
    Publishing country Netherlands
    Document type Book ; Conference proceedings
    HBZ-ID HT015837459
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

To top